| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Safinamide methansulfonate |
| Brand | Xadago® |
| Indication | For the treatment of adult patients with idiopathic Parkinson’s disease. |
| Assessment Process | |
| Rapid review commissioned | 14/06/2016 |
| Rapid review completed | 06/07/2016 |
| Rapid review outcome | Reimbursement Not Recommended |